title: [Eradication of Helicobacter pylori in patients with recurrent abdominal pain using a triple drug treatment].
abstract: BACKGROUND
  Different antibiotics, antagonist H2 and others have been used for elimination and/or eradication of Helicobacter pylori.
  
  
  OBJECTIVE
  Evaluate elimination of Helicobacter pylori with amoxicillin, bismuth subsalicylate and ranitidine; and the improvement of recurrent abdominal pain.
  
  
  METHODS
  20 children with recurrent abdominal pain associated to gastritis and histologic identification of Helicobacter pylori were studied under a period of 18 months (January 1992 to June 1993), at Instituto Nacional de Pediatría, México, D.F. All children were treated simultaneously with: Amoxicillin, 15 days, plus ranitidine and bismuth subsalicylate for one month.
  
  
  RESULTS
  Helicobacter pylori was eliminated in 14 of 20 children studied. All these children had an important improvement of recurrent abdominal pain.
  
  
  CONCLUSIONS
  Elimination of Helicobacter pylori and clinical improvement was present in 14 of 20 children studied (70%).
authors.affiliation: Servicio de Gastroenterología y Nutrición, Instituto Nacional de Pediatría, Col. Insurgentes-Cuicuilco.
authors.forename: J
authors.initials: J
authors.lastname: Ramírez Mayans
authors.forename: E
authors.initials: E
authors.lastname: Zamora Dávila
authors.forename: R
authors.initials: R
authors.lastname: Cervantes Bustamante
authors.forename: N
authors.initials: N
authors.lastname: Mata Rivera
authors.forename: C I
authors.initials: CI
authors.lastname: Oyervides García
authors.forename: F
authors.initials: F
authors.lastname: Cuevas Schacht
authors.forename: M C
authors.initials: MC
authors.lastname: Sosa de Martínez
mesh_terms: D015746:Abdominal Pain / Q000188:drug therapy*; D000658:Amoxicillin / Q000008:administration & dosage* / Q000494:pharmacology; D000897:Anti-Ulcer Agents / Q000008:administration & dosage* / Q000494:pharmacology; D001729:Bismuth / Q000008:administration & dosage* / Q000494:pharmacology; D002648:Child; D005260:Female; D016481:Helicobacter Infections / Q000188:drug therapy*; D016480:Helicobacter pylori / Q000187:drug effects*; D006801:Humans; D008137:Longitudinal Studies; D008297:Male; D009942:Organometallic Compounds / Q000008:administration & dosage* / Q000494:pharmacology; D010406:Penicillins / Q000008:administration & dosage* / Q000494:pharmacology; D011446:Prospective Studies; D011899:Ranitidine / Q000008:administration & dosage* / Q000494:pharmacology; D012008:Recurrence; D012459:Salicylates / Q000008:administration & dosage* / Q000494:pharmacology
chemical_list: D000897:Anti-Ulcer Agents; D009942:Organometallic Compounds; D010406:Penicillins; D012459:Salicylates; C015715:bismuth subsalicylate; D000658:Amoxicillin; D011899:Ranitidine; D001729:Bismuth
vernacular_title: Erradicación del Helicobacter pylori en pacientes con dolor abdominal recidivante con un triple esquema de tratamiento.